(IQVIA: Research Triangle Park, NC) -- IQVIA, a global provider of clinical research services, commercial insights, and healthcare intelligence, has announced that the global independent research and analysis firm Everest Group has named IQVIA a “front-runner generative AI leader” for the life sciences industry in its recent report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.”

IQVIA was the only clinical research organization to receive the highest ranking  in the report, which measures the value impact of end-to-end generative AI capabilities for 15 broad-based AI companies, clinical research organizations, and life sciences specialists and niche firms. IQVIA is also the only clinical research organization with a dedicated technology business unit to receive this designation.

“By striving for operational excellence and emphasizing the need for responsible AI governance, IQVIA is taking a thoughtful approach to its generative AI strategy, scaling select use cases from concept to deployment to maximize value across the stages of the product life cycle,” says Aastha Malik, practice director, Everest Group.

The report ranks IQVIA among five front-runners and says it showed industry leadership in its innovative strategic integrations of generative AI capabilities through various stages of research and development that help enable new ways of working. This includes several IQVIA Healthcare-Grade AI solutions to identify nuances in the patient journey for improved clinical trial design, enhanced product commercialization strategies with deeper provider engagement analytics, and precise market access insights.

“Today’s life sciences and healthcare organizations are looking to balance AI innovation with continuous service delivery at high standards, striving for operational excellence,” says Harietta Eleftherochorinou, vice president of AI strategy and operations at IQVIA. “The pace of AI advancement is extremely fast, making it important to implement AI with effective governance and drive tangible results while incentivizing for AI experimentation and keeping up to date with emerging AI technologies. With Healthcare-Grade AI as our cornerstone for privacy, quality, and trust, and building on the insights from over a decade of AI solutions in the market, we are systematic in identifying the areas where AI makes a real difference, and moving effectively from AI ideas to operationalization to create real-world value for our customers and their patients.”

IQVIA is gaining recognition for its ability to drive innovation and operational efficiency throughout the R&D life cycle. Earlier this year, IQVIA AI Assistant, an interactive tool to revolutionize insight generation for the healthcare and life sciences industries, was recognized with the PM360 Innovation Award in the AI category.